BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35237802)

  • 21. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.
    Escobar-Morreale HF; Roldán B; Barrio R; Alonso M; Sancho J; de la Calle H; García-Robles R
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4182-7. PubMed ID: 11095451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.
    Lizneva D; Kirubakaran R; Mykhalchenko K; Suturina L; Chernukha G; Diamond MP; Azziz R
    Fertil Steril; 2016 Nov; 106(6):1510-1520.e2. PubMed ID: 27530062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome.
    Zhao X; Zhong J; Mo Y; Chen X; Chen Y; Yang D
    Int J Gynaecol Obstet; 2010 Feb; 108(2):148-51. PubMed ID: 19932893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis.
    Christ JP; Gunning MN; Fauser BCJM
    Reprod Biomed Online; 2017 Oct; 35(4):480-483. PubMed ID: 28733169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
    Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors.
    Sanchón R; Gambineri A; Alpañés M; Martínez-García MÁ; Pasquali R; Escobar-Morreale HF
    Hum Reprod; 2012 Apr; 27(4):1209-16. PubMed ID: 22343706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of polycystic ovary syndrome and related disorders in mexican women.
    Moran C; Tena G; Moran S; Ruiz P; Reyna R; Duque X
    Gynecol Obstet Invest; 2010; 69(4):274-280. PubMed ID: 20110726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis.
    Pea J; Bryan J; Wan C; Oldfield AL; Ganga K; Carter FE; Johnson LM; Lujan ME
    Hum Reprod Update; 2024 Jan; 30(1):109-130. PubMed ID: 37804097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set.
    Ganie MA; Rashid A; Baba MS; Zargar MA; Wani IA; Nisar S; Wani IA; Douhath S; Sriwastawa M; Geer MI; Asrar MM; Kutum R; Hassan S; Khan S; Rafi W; Bhat DA; Showkat W; Sahar T; Choh NA; Khurshid R; Mudassar S; Shah ZA; Shabir I; Sofi SA; Gupta N; Hafeez I; Sreenivas V
    Clin Endocrinol (Oxf); 2023 Dec; 99(6):566-578. PubMed ID: 37656656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
    Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
    Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.
    Rosenfield RL
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):412-9. PubMed ID: 25840648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J
    Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of idiopathic hirsutism: A systematic review and meta-analysis.
    Amiri M; Fallahzadeh A; Sheidaei A; Mahboobifard F; Ramezani Tehrani F
    J Cosmet Dermatol; 2022 Apr; 21(4):1419-1427. PubMed ID: 34185950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different pregnancy outcomes according to the polycystic ovary syndrome diagnostic criteria: a systematic review and meta-analysis of 79 studies.
    Chatzakis C; Tsakmaki E; Psomiadou A; Charitakis N; Eleftheriades M; Dinas K; Goulis D; Sotiriadis A
    Fertil Steril; 2022 Apr; 117(4):854-881. PubMed ID: 35120743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polycystic ovary syndrome: is there a rise in the prevalence?].
    Carmona-Ruiz IO; Saucedo-de la Llata E; Moraga-Sánchez MR; Romeu-Sarró A
    Ginecol Obstet Mex; 2015 Dec; 83(12):750-9. PubMed ID: 27290799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mild androgen phenotypes.
    Carmina E
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):207-20. PubMed ID: 16772152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
    Bizzarri C; Benevento D; Ravà L; Patera IP; Schiaffini R; Ciampalini P; Giannone G; Cappa M
    Fertil Steril; 2011 Dec; 96(6):1497-1502.e1. PubMed ID: 21982726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.